SCHEMBL16622858

SCHEMBL16622858

O=C(NC1CCCCC1)c1cc(C(=O)NC2CCCCC2)cc(-c2ccccc2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.64
RAB9A P51151 6/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
MEN1 O00255 3/20 0.64
KMT2A Q03164 3/20 0.64
CNR1 P21554 2/20 0.61
CNR2 P34972 2/20 0.61
ALDH1A1 P00352 1/20 0.60
LMNA P02545 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
GAA P10253 1/20 0.57
LHCGR P22888 1/20 0.57
S1PR1 P21453 1/20 0.57
SMYD3 Q9H7B4 1/20 0.56
PKM P14618 1/20 0.56
FAAH O00519 1/20 0.55
ERN1 O75460 1/20 0.54
CYP1A2 P05177 1/20 0.54
HPGD P15428 1/20 0.54
CYP2C19 P33261 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1928387 0.89 RAB9A (0.67) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL2980074 0.88 PKM (0.68) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL22308180 0.87 NPC1 (0.84) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL2983895 0.87 NPC1 (0.84) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL22289346 0.87 NPC1 (0.84) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL8161568 0.85 NPC1 (0.87) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL435720 0.85 KMT2A (0.69) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL2908851 0.85 KMT2A (0.69) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL9978790 0.85 KMT2A (0.69) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL2915946 0.85 KMT2A (0.69) NPC1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9882136-B2 Organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2018-01-30 US disclosed
EP-2858458-B1 ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO LTD (JP) 2017-05-31 EP disclosed
US-20150287920-A1 ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2015-10-08 US disclosed
EP-2858458-A1 ORGANIC ELECTROLUMINESCENT ELEMENT Hodogaya Chemical Co., Ltd. (JP) 2015-04-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150287920-A1 ORGANIC ELECTROLUMINESCENT DEVICE CDH1, STRA6, SLC39A7 NPC1 1060/4885RAB9A 732/4885SMN1; SMN2 4109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.